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ischaemia, infarction and heart failure [2, 4] . Transgenic mice with cardiac specific overexpression of Gsa have Ventricular arrhythmias occur frequently following acute increased incidence of arrhythmias and mortality [11] . The myocardial infarction, during reperfusion and in heart importance of locally mediated release of NA, with failure. They are the likely major cause of sudden cardiac subsequent activation of a -adrenoceptors, in ischaemia-1 death in the majority of instances and as such represent a reperfusion arrhythmias has been thoroughly investigated continuing and major cardiac health problem. The role of [12, 13] and a good correlation between the quantity of NA the sympathetic nervous system (SNS) in the genesis of release or the extent of a-AR activation and the severity of arrhythmias under these conditions has been extensively arrhythmias has been reported [12, 14, 15] . studied for many years. Nevertheless, the importance of There are, however, a number of studies implying the SNS activation in arrhythmogenesis remains controversial.
opposite, namely that activation of SNS is not an important This is again apparent in the current issue of Cardiovascu-or necessary antecedent of arrhythmias [3, 16] . Walker et al. lar Research, where the findings from two papers with have presented an elegant and novel approach to address apparently contradictory interpretations are presented [1, 2] . the role of SNS under conditions of myocardial ischaemia Numerous experimental approaches have been applied and infarction [1]. They firstly transplanted rat hearts into to manipulate the activity of the SNS, from dennervation the abdominal aorta of host rats and then, at various time and catecholamine depletion to cardiac sympathetic nerve points (1 h, 2, 5 and 10 days) after transplantation, stimulation or treatment with adrenergic agonists. These subjected both donor and native hearts to regional isstudies have been reviewed thoroughly [3] [4] [5] [6] [7] . Several lines chaemia. Thus, the paired donor and native hearts were of evidence have suggested an important or perhaps even under identical hormonal and circulatory conditions but pivotal role for SNS activation in initiating arrhythmias with a crucial difference in that only the native, but not the following myocardial infarction, reperfusion or heart fail-donor heart, was sympathetically innervated. They hypothure. Thus both high levels of circulating catecholamines as esized that any difference in arrhythmia incidence between well as increased cardiac noradrenaline (NA) spillover [8], donor and native hearts could then be attributed to the increased sympathetic nerve firing rates and suppressed presence of an intact innervation only to the native heart. baroreflex sensitivity are all associated with increased However, their findings clearly show that both hearts incidences of arrhythmias and mortality [5]. b-blockers experienced similar incidence of arrhythmias [1]. have been shown to be particularly beneficial in reducing There are several issues which need to be considered in cardiac mortality following myocardial infarction or heart relation to their model. First, the model does closely failure, although evidence that their mechanism is by an resemble the situation in cardiac transplantation with the anti-arrhythmic effect is less clear cut. There is strong exception that the transplanted rat heart did not perform evidence that ventricular fibrillation and sudden cardiac significant external work. The lack of the autonomic death may be triggered in some patients by psychologic control was demonstrated by unchanged heart rate followstressors [9, 10] . Activation of sympathetic nerves, espe-ing alterations in blood pressure or with ganglion bloccially stimulation of the left cervicothoracic stellate gang-kade. The NA content in the heart was not measured but it is likely to be small at least at the 10-day period. It is known that three days after chemical sympathectomy NA tibility to arrhythmias [22] [23] [24] . As dennervation sensitization increases the arrhythmia It may be useful to consider the attributes of an 'ideal' susceptibility [6] , it is thus possible that, in the presence of experiment needed to establish the importance of symreceptor supersensitivity, adrenergic activation occurs by pathoadrenergic activation in the genesis of arrhythmias. either increase in circulating catecholamines and possibly
The intervention should affect all SNS signal transduction local release of residual NA, which might still have been pathways (i.e. not only these mediated by bor a-adrenosufficient to contribute to arrhythmia development. Third, ceptors) but without producing confounding changes in considering a lower workload and the resultant energy alternative pathways which can ultimately lead to arrhythexpenditure in transplanted hearts, a lower arrhythmia mia development. The intervention should be cardiac incidence during ischaemia was expected but this was not specific and should inhibit responses to local activation of observed.
nerves as well as that in response to neural reflex activity.
Controversy over the role of the SNS is partly due to
The arrhythmias should be either initiated or abolished (or difficulty in manipulating the activity of the SNS, par-at least substantially reduced) by manipulating SNS activiticularly in eliminating its influence. The arrhythmogenic ty and signal pathway at a time immediately preceding the outcome of SNS activation has been demonstrated in the onset of arrhythmias. Whilst at the present time there majority of studies inducing nerve activation by either seems not prospect of such an 'ideal experiment' being electric stimulation or other means [2,4,6,7]. There is conducted, its features can be used as a yardstick against evidence that in hearts subjected to infarction or failure, which actual experimental setting may be measured. With sympathetic nerve stimulation results in heterogeneous, the progress in the transgenic techniques, mouse carrather than a homogenous, adrenergic activation, which is diophysiology and induced models of myocardial infarcmore arrhythmogenic [2, 6, 17] . Although it has been shown tion and heart failure, it is likely that the use of mouse that co-transmitters, such as neuropeptide Y, have signifi-lines, with the SNS and adrenergic signal pathways cant electrophysiological actions [18, 19] , the potential enhanced or abolished, may be a novel approach to address synergistic effects of NA and co-transmitters on perturba-this question, although the severity of arrhythmias appears tions in electrophysiology under pathological conditions to be lower in the mouse compared to other species [25] . has been little studied. While neuronally mediated NA
The mouse lines of potential use may include cardiac release can be prevented by acute sympathectomy, local specific overexpression or deletion of nerve growth factor release of NA can still trigger arrhythmias during is-which determines the extent of sympathetic innervation chaemia and reperfusion [12, 13] . As discussed above, and the catecholamine content in the heart, and of aand chronic dennervation is confounded by the post-junctional b-adrenoceptors [26] [27] [28] [29] [30] . supersensitivity of adrenoceptors and signal pathway.
It is generally agreed that structural cardiac abnormalities (ischaemia and infarct, cardiomyopathy, hyper-References trophy, ventricular remodeling) provide substrates on which a triggering mechanism operates to initiate arrhyth- [ maintained glycolysis would occur leading to more pro-Circulation 1993;87:1442-1450.
